Cochrane Abstracts
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Immunosuppressive Treatment for Primary Membranous Nephropathy in Adults With Nephrotic Syndrome." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431061/all/Immunosuppressive_treatment_for_primary_membranous_nephropathy_in_adults_with_nephrotic_syndrome.
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431061/all/Immunosuppressive_treatment_for_primary_membranous_nephropathy_in_adults_with_nephrotic_syndrome. Accessed January 26, 2025.
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431061/all/Immunosuppressive_treatment_for_primary_membranous_nephropathy_in_adults_with_nephrotic_syndrome
Immunosuppressive Treatment for Primary Membranous Nephropathy in Adults With Nephrotic Syndrome [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431061/all/Immunosuppressive_treatment_for_primary_membranous_nephropathy_in_adults_with_nephrotic_syndrome.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome
ID - 431061
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431061/all/Immunosuppressive_treatment_for_primary_membranous_nephropathy_in_adults_with_nephrotic_syndrome
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
